Using applied lung physiology to understand COVID-19 patterns

Affiliations

¹ Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK; Intensive Care Unit, Charing Cross Hospital, London, UK. Electronic address: m.komorowski14@imperial.ac.uk.
² Division of Pulmonary and Critical Care Medicine, University of Utah, Salt Lake City, UT, USA.

Editorial

Matthieu Komorowski et al. Br J Anaesth. 2020 Sep.

. 2020 Sep;125(3):250-253.

doi: 10.1016/j.bja.2020.05.019. Epub 2020 May 27.

¹ Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK; Intensive Care Unit, Charing Cross Hospital, London, UK. Electronic address: m.komorowski14@imperial.ac.uk.
² Division of Pulmonary and Critical Care Medicine, University of Utah, Salt Lake City, UT, USA.

No abstract available

Keywords: ARDS; COVID-19; coronavirus; phenotype; physiology; respiration; ventilation.

Comment on

COVID-19 patients with respiratory failure: what can we learn from aviation medicine?
Ottestad W, Søvik S. Ottestad W, et al. Br J Anaesth. 2020 Sep;125(3):e280-e281. doi: 10.1016/j.bja.2020.04.012. Epub 2020 Apr 18. Br J Anaesth. 2020. PMID: 32362340 Free PMC article. No abstract available.

1. Charbonneau A., Moss B., Marriott L. The surprising patterns of health and disease. Sci Scope (Wash DC) 2015;38:64–70. - PMC - PubMed
1. Hides J., Lambrecht G., Ramdharry G., Cusack R., Bloomberg J., Stokes M. Parallels between astronauts and terrestrial patients—taking physiotherapy rehabilitation “to infinity and beyond. Musculoskelet Sci Pract. 2017;27:S32–S37. - PubMed
1. Gattinoni L., Chiumello D., Caironi P. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med. 2020 doi: 10.1007/s00134-020-06033-2. [Accessed 6 May 2020] - DOI - PMC - PubMed
1. Marini J.J., Gattinoni L. Management of COVID-19 respiratory distress. JAMA. 2020 https://jamanetwork.com/journals/jama/fullarticle/2765302 Available from. - PubMed
1. Solaimanzadeh I. Acetazolamide, nifedipine and phosphodiesterase inhibitors: rationale for their utilization as adjunctive countermeasures in the treatment of coronavirus disease 2019 (COVID-19) Cureus. 2020:12. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096066/ Available from. - PMC - PubMed